PTN Stock Analysis: Buy, Sell, or Hold?
$9.33
0.27 (2.98%)
▲
5d:
-7.58%
30d:
-27.34%
90d:
-15.26%
HOLD
LOW Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Nov 13, 2026
Get Alerted When PTN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: PTN shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: PTN shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: PTN is currently trading at $9.33, which is considered oversold relative to its 30-day fair value range of $9.50 to $12.14.
Technical Outlook: Technically, PTN is in a downtrend. Immediate support is located at $8.67, while resistance sits at $11.73.
Market Sentiment: PTN scores 65/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $53.50 (+473.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, PTN is in a downtrend. Immediate support is located at $8.67, while resistance sits at $11.73.
Market Sentiment: PTN scores 65/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $53.50 (+473.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$9.50 -
$12.14
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
94.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (65/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 473.4% below Wall St target ($53.50)
- CAUTION: Bottoming setup, but lagging the sector by 43% over 20 days — wait for relative strength
- CAUTION: 5-day price weakness (-7.6%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$9.50 -
$12.14
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$8.67
Resistance Level
$11.73
Current Trend
Downtrend
Technical data as of
Oct 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-3.84
Wall Street Target
$53.50
(+473.4%)
Revenue Growth (YoY)
-80.1%
Profit Margin
-63.5%
Share & Embed Analysis
Last updated: October 04, 2026 4:37 AM ET
Data refreshes hourly during market hours. Next update: 5:37 AM
Data refreshes hourly during market hours. Next update: 5:37 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is PTN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$75 | 60 BUY |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$28 | 53 HOLD |
|
RCKT
Rocket Pharmaceuticals I… |
STRONG BUY
18 analysts |
$9 | 58 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$95 | 57 HOLD |
|
BEAM
Beam Therapeutics Inc |
STRONG BUY
17 analysts |
$52 | 66 BUY |